Skip to main navigation Skip to search Skip to main content

European Position Paper on Rhinosinusitis and Nasal Polyps 2020

  • W. J. Fokkens
  • , V. J. Lund
  • , C. Hopkins
  • , P. W. Hellings
  • , R. Kern
  • , S. Reitsma
  • , S. Toppila-Salmi
  • , M. Bernal-Sprekelsen
  • , J. Mullol
  • , I. Alobid
  • , W. Terezinha Anselmo-Lima
  • , C. Bachert
  • , F. Baroody
  • , C. von Buchwald
  • , A. Cervin
  • , N. Cohen
  • , J. Constantinidis
  • , L. De Gabory
  • , M. Desrosiers
  • , Z. Diamant
  • R. G. Douglas, P. H. Gevaert, A. Hafner, R. J. Harvey, G. F. Joos, L. Kalogjera, A. Knill, J. H. Kocks, B. N. Landis, J. Limpens, S. Lebeer, O. Lourenco, C. Meco, P. M. Matricardi, L. O'Mahony, C. M. Philpott, D. Ryan, R. Schlosser, B. Senior, T. L. Smith, T. Teeling, P. V. Tomazic, D. Y. Wang, D. Wang, L. Zhang, A. M. Agius, C. Ahlstrom-Emanuelsson, R. Alabri, S. Albu, S. Alhabash, A. Aleksic, M. Aloulah, M. Al-Qudah, S. Alsaleh, M. A. Baban, T. Baudoin, T. Balvers, P. Battaglia, J. D. Bedoya, A. Beule, K. M. Bofares, I. Braverman, E. Brozek-Madry, B. Richard, C. Callejas, S. Carrie, L. Caulley, D. Chussi, E. de Corso, A. Coste, U. El Hadi, A. Elfarouk, P. H. Eloy, S. Farrokhi, G. Felisati, M. D. Ferrari, R. Fishchuk, W. Grayson, P. M. Goncalves, B. Grdinic, V. Grgic, A. W. Hamizan, J. V. Heinichen, S. Husain, T. I. Ping, J. Ivaska, F. Jakimovska, L. Jovancevic, E. Kakande, R. Kamel, S. Karpischenko, H. H. Kariyawasam, H. Kawauchi, A. Kjeldsen, L. Klimek, A. Krzeski, G. Kopacheva Barsova, S. W. Kim, D. Lal, J. J. Letort, A. Lopatin, A. Mahdjoubi, A. Mesbahi, J. Netkovski, D. Nyenbue Tshipukane, A. Obando-Valverde, M. Okano, M. Onerci, Y. K. Ong, R. Orlandi, N. Otori, K. Ouennoughy, M. Ozkan, A. Peric, J. Plzak, E. Prokopakis, N. Prepageran, A. Psaltis, B. Pugin, M. Raftopulos, P. Rombaux, H. Riechelmann, S. Sahtout, C. C. Sarafoleanu, K. Searyoh, C. S. Rhee, J. Shi, M. Shkoukani, A. K. Shukuryan, M. Sicak, D. Smyth, K. Snidvongs, T. Soklic Kosak, P. Stjarne, B. Sutikno, S. Steinsvag, P. Tantilipikorn, S. Thanaviratananich, T. Tran, J. Urbancic, A. Valiulius, C. Vasquez de Aparicio, D. Vicheva, P. M. Virkkula, G. Vicente, R. Voegels, M. M. Wagenmann, R. S. Wardani, A. Welge-Lussen, I. Witterick, E. Wright, D. Zabolotniy, B. Zsolt, C. P. Zwetsloot
  • Amsterdam University Medical Centers
  • Royal National Throat, Nose and Ear Hospital
  • Guy's and St Thomas' NHS Foundation Trust
  • KU Leuven
  • Ghent University
  • Northwestern University
  • Hospital District of Helsinki and Uusimaa
  • University of Valencia
  • University of Barcelona
  • Universidade de São Paulo
  • Stockholm University
  • The University of Chicago
  • University of Copenhagen
  • Royal Brisbane and Women's Hospital
  • University of Queensland
  • University of Pennsylvania
  • Aristotle University of Thessaloniki
  • Groupe hospitalier Pellegrin
  • University of Montreal
  • Lund University
  • Research Director Respiratory and Allergy
  • Charles University
  • The University of Auckland
  • University of Zagreb
  • Macquarie University
  • Sisters of Charity Hospital
  • Patient Representative
  • Observational Pragmatic Research Institute
  • University of Geneva
  • University of Antwerp
  • University of Beira Interior
  • Ankara University
  • Paracelsus Private Medical University
  • Charité – Universitätsmedizin Berlin
  • University of East Anglia
  • James Paget University Hospitals NHS Foundation Trust
  • University of Edinburgh
  • Optimum Patient Care
  • Medical University of South Carolina
  • University of North Carolina at Chapel Hill
  • Oregon Health and Science University
  • Task Force Healthcare
  • Medical University of Graz
  • National University of Singapore
  • ENT Department
  • Fudan University
  • Capital Medical University
  • University of Malta
  • Sultan Qaboos University
  • Iuliu Hatieganu University of Medicine and Pharmacy
  • Department of ENT
  • University of Banja Luka
  • King Saud University
  • Jordan University of Science and Technology
  • University of Sulaimani
  • Leiden University
  • University of Insubria
  • Universidad de Antioquia
  • University of Münster
  • Omar Al-Mukhtar University
  • Hille Yaffe Medical Center Israel
  • Medical University of Warsaw
  • Makerere University
  • Pontificia Universidad Católica de Chile
  • Newcastle University
  • University of Ottawa
  • Kilimanjaro Christian Medical University College
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • Université Paris-Est-Créteil
  • American University of Beirut
  • Cairo University
  • CHU UCL Namur
  • Persian Gulf Tropical Medicine Research Center
  • Bushehr University of Medical Sciences
  • University of Milan
  • Central city clinical hospital of lvano-Frankivsk city council
  • University of Alabama at Birmingham
  • Santa Maria da Feira
  • General Hospital Pula
  • Universiti Kebangsaan Malaysia
  • Universidad Nacional de Asunción
  • Universiti Malaysia Sarawak
  • Vilnius University
  • SS Cyril and Methodius University in Skopje
  • University of Novi Sad
  • Mulago Referral Hospital
  • Nose and Speech
  • Pavlov First State Medical University of St. Petersburg
  • Royal National ENT Hospital
  • Shimane University
  • University of Southern Denmark
  • Center for Rhinology and Allergology
  • Kyung Hee University
  • Mayo Clinic Scottsdale-Phoenix, Arizona
  • Pontifica Catholic University of Ecuador
  • Policlinic No.1 - Senior ENT Consultant and Surgeon
  • President of Russian Rhinologic Society
  • Ordibehesht Hospital, Shiraz
  • Université de Kinshasa
  • University of Costa Rica
  • International University of Health and Welfare
  • Department of Otorhinolaryngology
  • University of Utah
  • The Jikei University School of Medicine
  • Department of Otorhinolaryngology-Head and Neck Surgery
  • University of Health Sciences
  • University of Defence in Belgrade
  • University of Crete
  • University of Malaya
  • University of Adelaide
  • Swiss Federal Institute of Technology Zurich
  • Royal Australian College of Surgeons
  • Université catholique de Louvain
  • Ulm University
  • Université de Tunis El Manar
  • Carol Davila University of Medicine and Pharmacy
  • University of Ghana
  • Seoul National University
  • Sun Yat-Sen University
  • Cleveland Clinic Abu Dhabi
  • Yerevan State Medical University
  • Slovak Medical University
  • Royal College of Surgeons in Ireland
  • Chulalongkorn University
  • University Medical Centre
  • Karolinska Institutet
  • Universitas Airlangga
  • University of Bergen
  • Mahidol University
  • Vietnam National University Ho Chi Minh City
  • University of Ljubljana
  • University of El Salvador
  • Medical University of Plovdiv
  • Helsinki University Hospital
  • St. Luke's Medical Centre
  • Heinrich Heine University Düsseldorf
  • University of Indonesia
  • University of Basel
  • University of Alberta
  • National Academy of Medical Sciences of Ukraine
  • University of Szeged
  • Netherlandsn

Research output: Contribution to journalArticlepeer-review

Abstract

The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become more involved in the management and treatment of rhinosinusitis since the publication of the last EPOS document, including pharmacists, nurses, specialised care givers and indeed patients themselves, who employ increasing self-management of their condition using over the counter treatments. The document provides suggestions for future research in this area and offers updated guidance for definitions and outcome measurements in research in different settings. EPOS2020 contains chapters on definitions and classification where we have defined a large number of terms and indicated preferred terms. A new classification of CRS into primary and secondary CRS and further division into localized and diffuse disease, based on anatomic distribution is proposed. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, allergic rhinitis, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. All available evidence for the management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is systematically reviewed and integrated care pathways based on the evidence are proposed. Despite considerable increases in the amount of quality publications in recent years, a large number of practical clinical questions remain. It was agreed that the best way to address these was to conduct a Delphi exercise . The results have been integrated into the respective sections. Last but not least, advice for patients and pharmacists and a new list of research needs are included. The full document can be downloaded for free on the website of this journal: http://www.rhinologyjournal.com.

Original languageEnglish
Pages (from-to)1-464
Number of pages464
JournalRhinology
Volume58
DOIs
Publication statusPublished - 20 Feb 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'European Position Paper on Rhinosinusitis and Nasal Polyps 2020'. Together they form a unique fingerprint.

Cite this